CBP and p300: HATs for different occasions

Biochemical Pharmacology

Volumn 68, Issue 6, 2004, Pages 1145-1155

  Kalkhoven, Eric ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cAMP response element binding protein; CBP; CREB; CREB binding protein; factor acetyltransferase; FAT; HAT; histone acetyltransferase; mixed lineage leukaemia protein; MLL; monocytic leukaemia zinc finger protein; MORF; MOZ; MOZ related factor; PHD

Indexed keywords

ACYLTRANSFERASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; PROTEIN P300; RNA POLYMERASE II;

CELL ASSAY; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME SPECIFICITY; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

ACETYLTRANSFERASES; ANIMALS; CELL CYCLE PROTEINS; CREB-BINDING PROTEIN; HISTONE ACETYLTRANSFERASES; HUMANS; NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 4143098311     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.03.045     Document Type: Conference Paper

References (149)

1. Kingston R.E., Narlikar G.J. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 13:1999;2339-2352
2. Cheung W.L., Briggs S.D., Allis C.D. Acetylation and chromosomal functions. Curr. Opin. Cell Biol. 12:2000;326-333
3. Kuo M.H., Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays. 20:1998;615-626
4. Kouzarides T. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12:2002;198-209
5. Cheung P., Allis C.D., Sassone-Corsi P. Signaling to chromatin through histone modifications. Cell. 103:2000;263-271
6. Shiio Y., Eisenman R.N. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. USA. 100:2003;13225-13230
7. Jason L.J., Moore S.C., Lewis J.D., Lindsey G., Ausio J. Histone ubiquitination: a tagging tail unfolds? Bioessays. 24:2002;166-174
8. Winston F., Allis C.D. The bromodomain: a chromatin-targeting module? Nat. Struct. Biol. 6:1999;601-604
9. Turner B.M. Histone acetylation and an epigenetic code. Bioessays. 22:2000;836-845
10. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature. 403:2000;41-45
11. Agalioti T., Lomvardas S., Parekh B., Yie J., Maniatis T., Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell. 103:2000;667-678
12. Cosma M.P., Tanaka T., Nasmyth K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell. 97:1999;299-311
13. Martens J.H., Verlaan M., Kalkhoven E., Zantema A. Cascade of distinct histone modifications during collagenase gene activation. Mol. Cell. Biol. 23:2003;1808-1816
14. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:2000;843-852
15. Soutoglou E., Talianidis I. Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science. 295:2002;1901-1904
16. Arany Z., Sellers W.R., Livingston D.M., Eckner R. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell. 77:1994;799-800
17. Yuan L.W., Giordano A. Acetyltransferase machinery conserved in p300/CBP-family proteins. Oncogene. 21:2002;2253-2260
18. Bordoli L., Netsch M., Luthi U., Lutz W., Eckner R. Plant orthologs of p300/CBP: conservation of a core domain in metazoan p300/CBP acetyltransferase-related proteins. Nucl. Acids Res. 29:2001;589-597
19. Partanen A., Motoyama J., Hui C.C. Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis. Int. J. Dev. Biol. 43:1999;487-494
20. Yuan W., Condorelli G., Caruso M., Felsani A., Giordano A. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271:1996;9009-9013
21. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-226
22. Neish A.S., Anderson S.F., Schlegel B.P., Wei W., Parvin J.D. Factors associated with the mammalian RNA polymerase II holoenzyme. Nucl. Acids Res. 26:1998;847-853
23. Nakajima T., Uchida C., Anderson S.F., Lee C.G., Hurwitz J., Parvin J.D., et al. RNA helicase A mediates association of CBP with RNA polymerase II. Cell. 90:1997;1107-1112
24. Nakajima T., Uchida C., Anderson S.F., Parvin J.D., Montminy M. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11:1997;738-747
25. Cho H., Orphanides G., Sun X., Yang X.J., Ogryzko V., Lees E., et al. A human RNA polymerase II complex containing factors that modify chromatin structure. Mol. Cell. Biol. 18:1998;5355-5363
26. Chan H.M., La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2001;2363-2373
27. Vo N., Goodman R.H. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276:2001;13505-13508
28. Ait-Si-Ali S., Ramirez S., Barre F.X., Dkhissi F., Magnaghi-Jaulin L., Girault J.A., et al. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature. 396:1998;184-186
29. Ait-Si-Ali S., Carlisi D., Ramirez S., Upegui-Gonzalez L.C., Duquet A., Robin P., et al. Phosphorylation by p44 MAP Kinase/ERK1 stimulates CBP histone acetyl transferase activity in vitro. Biochem. Biophys. Res. Commun. 262:1999;157-162
30. Janknecht R., Nordheim A. MAP kinase-dependent transcriptional coactivation by Elk-1 and its cofactor CBP. Biochem. Biophys. Res. Commun. 228:1996;831-837
31. Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A., Snowden A.W., et al. P300 transcriptional repression is mediated by SUMO modification. Mol. Cell. 11:2003;1043-1054
32. Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., et al. A transcriptional switch mediated by cofactor methylation. Science. 294:2001;2507-2511
33. Chevillard-Briet M., Trouche D., Vandel L. Control of CBP co-activating activity by arginine methylation. EMBO J. 21:2002;5457-5466
34. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959
35. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 384:1996;641-643
36. Kundu T.K., Palhan V.B., Wang Z., An W., Cole P.A., Roeder R.G. Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. Mol. Cell. 6:2000;551-561
37. Martinez-Balbas M.A., Bannister A.J., Martin K., Haus-Seuffert P., Meisterernst M., Kouzarides T. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17:1998;2886-2893
38. Neuwald A.F., Landsman D. GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein. Trends Biochem. Sci. 22:1997;154-155
39. Yan Y., Barlev N.A., Haley R.H., Berger S.L., Marmorstein R. Crystal structure of yeast esa1 suggests a unified mechanism for catalysis and substrate binding by histone acetyltransferases. Mol. Cell. 6:2000;1195-1205
40. Marmorstein R., Roth S.Y. Histone acetyltransferases: function, structure, and catalysis. Curr. Opin. Genet. Dev. 11:2001;155-161
41. Aasland R., Gibson T.J., Stewart A.F. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem. Sci. 20:1995;56-59
42. Saha V., Chaplin T., Gregorini A., Ayton P., Young B.D. The leukemia-associated-protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc. Natl. Acad. Sci. USA. 92:1995;9737-9741
43. Koken M.H., Saib A., de The H. A C4HC3 zinc finger motif. CR Acad. Sci. III. 318:1995;733-739
44. Bordoli L., Husser S., Luthi U., Netsch M., Osmani H., Eckner R. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity. Nucl. Acids Res. 29:2001;4462-4471
45. Kalkhoven E., Teunissen H., Houweling A., Verrijzer C.P., Zantema A. The PHD type zinc finger is an integral part of the CBP acetyltransferase domain. Mol. Cell. Biol. 22:2002;1961-1970
46. Jeanmougin F., Wurtz J.M., Le Douarin B., Chambon P., Losson R. The bromodomain revisited. Trends Biochem. Sci. 22:1997;151-153
47. Dhalluin C., Carlson J.E., Zeng L., He C., Aggarwal A.K., Zhou M.M. Structure and ligand of a histone acetyltransferase bromodomain. Nature. 399:1999;491-496
48. Jacobson R.H., Ladurner A.G., King D.S., Tjian R. Structure and function of a human TAFII250 double bromodomain module. Science. 288:2000;1422-1425
49. Manning E.T., Ikehara T., Ito T., Kadonaga J.T., Kraus W.L. p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol. Cell. Biol. 21:2001;3876-3887
50. Ragvin A., Valvatne H., Erdal S., Arskog V., Tufteland K.R., Breen K., et al. Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300. J. Mol. Biol. 337:2004;773-788
51. Schiltz R.L., Mizzen C.A., Vassilev A., Cook R.G., Allis C.D., Nakatani Y. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J. Biol. Chem. 274:1999;1189-1192
52. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:2000;435-459
53. Yang X.J. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucl. Acids Res. 32:2004;959-976
54. Chen H., Lin R.J., Xie W., Wilpitz D., Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 98:1999;675-686
55. Munshi N., Merika M., Yie J., Senger K., Chen G., Thanos D. Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell. 2:1998;457-467
56. Soutoglou E., Katrakili N., Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol. Cell. 5:2000;745-751
57. Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 19:2000;662-671
58. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., et al. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 279:1998;703-707
59. Kraus W.L., Manning E.T., Kadonaga J.T. Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol. Cell. Biol. 19:1999;8123-8135
60. Kurokawa R., Kalafus D., Ogliastro M.H., Kioussi C., Xu L., Torchia J., et al. Differential use of CREB binding protein-coactivator complexes. Science. 279:1998;700-703
61. Hasan S., Hassa P.O., Imhof R., Hottiger M.O. Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis. Nature. 410:2001;387-391
62. Hasan S., Stucki M., Hassa P.O., Imhof R., Gehrig P., Hunziker P., et al. Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300. Mol. Cell. 7:2001;1221-1231
63. Hasan S., El Andaloussi N., Hardeland U., Hassa P.O., Burki C., Imhof R., et al. Acetylation regulates the DNA end-trimming activity of DNA polymerase beta. Mol. Cell. 10:2002;1213-1222
64. Tini M., Benecke A., Um S.J., Torchia J., Evans R.M., Chambon P. Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Mol. Cell. 9:2002;265-277
65. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527
66. Ait-Si-Ali S., Polesskaya A., Filleur S., Ferreira R., Duquet A., Robin P., et al. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition. Oncogene. 19:2000;2430-2437
67. Grossman S.R., Perez M., Kung A.L., Joseph M., Mansur C., Xiao Z.X., et al. Livingston DM, p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell. 2:1998;405-415
68. Grossman S.R., Deato M.E., Brignone C., Chan H.M., Kung A.L., Tagami H., et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science. 300:2003;342-344
69. Bannister A.J., Miska E.A., Gorlich D., Kouzarides T. Acetylation of importin-alpha nuclear import factors by CBP/p300. Curr. Biol. 10:2000S;467-470
70. Klochendler-Yeivin A., Yaniv M. Chromatin modifiers and tumor suppression. Biochim. Biophys. Acta. 1551:2001;M1-M10
71. Timmermann S., Lehrmann H., Polesskaya A., Harel-Bellan A. Histone acetylation and disease. Cell Mol. Life Sci. 58:2001;728-736
72. Cairns B.R. Emerging roles for chromatin remodeling in cancer biology. Trends Cell Biol. 11:2001;S15-S21
73. Giles R.H., Peters D.J., Breuning M.H. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14:1998;178-183
74. Rubinstein J.H., Taybi H. Broad thumbs and toes and facial abnormalities. Am. J. Dis. Child. 105:1963;588-608
75. Miller R.W., Rubinstein J.H. Tumors in Rubinstein-Taybi syndrome. Am. J. Med. Genet. 56:1995;112-115
76. Kalkhoven E., Roelfsema J.H., Teunissen H., den Boer A., Ariyurek Y., Zantema A., et al. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum. Mol. Genet. 12:2003;441-450
77. Tanaka Y., Naruse I., Maekawa T., Masuya H., Shiroishi T., Ishii S. Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc. Natl. Acad. Sci. USA. 94:1997;10215-10220
78. Oike Y., Hata A., Mamiya T., Kaname T., Noda Y., Suzuki M., et al. Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism. Hum. Mol. Genet. 8:1999;387-396
79. Kung A.L., Rebel V.I., Bronson R.T., Ch'ng L.E., Sieff C.A., Livingston D.M., et al. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14:2000;272-277
80. Murata T., Kurokawa R., Krones A., Tatsumi K., Ishii M., Taki T., et al. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum. Mol. Genet. 10:2001;1071-1076
81. Mitsiou D.J., Stunnenberg H.G. p300 is involved in formation of the TBP-TFIIA-containing basal transcription complex, TAC. EMBO J. 22:2003;4501-4511
82. Bartsch O., Locher K., Meinecke P., Kress W., Seemanova E., Wagner A., et al. Molecular studies in 10 cases of Rubinstein-Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP. J. Med. Genet. 39:2002;496-501
83. Petrij F., Giles R.H., Dauwerse H.G., Saris J.J., Hennekam R.C., Masuno M., et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 376:1995;348-351
84. Sobulo O.M., Borrow J., Tomek R., Reshmi S., Harden A., Schlegelberger B., et al. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc. Natl. Acad. Sci. USA. 94:1997;8732-8737
85. Taki T., Sako M., Tsuchida M., Hayashi Y. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood. 89:1997;3945-3950
86. Champagne N., Bertos N.R., Pelletier N., Wang A.H., Vezmar M., Yang Y., et al. Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein. J. Biol. Chem. 274:1999;28528-28536
87. Champagne N., Pelletier N., Yang X.J. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene. 20:2001;404-409
88. Nakamura T., Mori T., Tada S., Krajewski W., Rozovskaia T., Wassell R., et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell. 10:2002;1119-1128
89. Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell. 10:2002;1107-1117
90. Kitabayashi I., Aikawa Y., Nguyen L.A., Yokoyama A., Ohki M. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J. 20:2001;7184-7196
91. Lavau C., Du C., Thirman M., Zeleznik-Le N. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J. 19:2000;4655-4664
92. Muraoka M., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Shitara N., Chong J.M., et al. p300 gene alterations in colorectal and gastric carcinomas. Oncogene. 12:1996;1565-1569
93. Gayther S.A., Batley S.J., Linger L., Bannister A., Thorpe K., Chin S.F., et al. Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24:2000;300-303
94. Ionov Y., Nowak N., Perucho M., Markowitz S., Cowell J.K. Manipulation of nonsense mediated decay identifies gene mutations in colon cancer cells with microsatellite instability. Oncogene. 23:2004;639-645
95. Ionov Y., Matsui S.I., Cowell J.K. A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA. 101:2004;1273-1278
96. Ozdag H., Batley S.J., Forsti A., Iyer N.G., Daigo Y., Boutell J., et al. Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours. Brit. J. Cancer. 87:2002;1162-1165
97. Ito A., Lai C.H., Zhao X., Saito S., Hamilton M.H., Appella E., et al. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J. 20:2001;1331-1340
98. Ohshima T., Suganuma T., Ikeda M. A novel mutation lacking the bromodomain of the transcriptional coactivator p300 in the SiHa cervical carcinoma cell line. Biochem. Biophys. Res. Commun. 281:2001;569-575
99. Knudson A.G. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 68:1971;820-823
100. Goodman R.H., Smolik S. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:2000;1553-1577
101. Suganuma T., Kawabata M., Ohshima T., Ikeda M.A. Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator. Proc. Natl. Acad. Sci. USA. 99:2002;13073-13078
102. Zoghbi H.Y., Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23:2000;217-247
103. Nucifora F.C. Jr., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., et al. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 291:2001;2423-2438
104. McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., et al. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9:2000;2197-2202
105. Yamada M., Wood J.D., Shimohata T., Hayashi S., Tsuji S., Ross C.A., et al. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann. Neurol. 49:2001;14-23
106. Shimohata T., Nakajima T., Yamada M., Uchida C., Onodera O., Naruse S., et al. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet. 26:2000;29-36
107. Taylor J.P., Taye A.A., Campbell C., Kazemi-Esfarjani P., Fischbeck K.H., Min K.T. Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein. Genes Dev. 17:2003;1463-1468
108. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 413:2001;739-743
109. Rouaux C., Jokic N., Mbebi C., Boutillier S., Loeffler J.P., Boutillier A.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 22:2003;6537-6549
110. Marambaud P., Wen P.H., Dutt A., Shioi J., Takashima A., Siman R., et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell. 114:2003;635-645
111. Brouillard F., Cremisi C.E. Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells. J. Biol. Chem. 278:2003;39509-39516
112. Yuan L.W., Soh J.W., Weinstein I.B. Inhibition of histone acetyltransferase function of p300 by PKCdelta. Biochim. Biophys. Acta. 1592:2002;205-211
113. Chen C.J., Deng Z., Kim A.Y., Blobel G.A., Lieberman P.M. Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol. Cell. Biol. 21:2001;476-487
114. Soutoglou E., Viollet B., Vaxillaire M., Yaniv M., Pontoglio M., Talianidis I. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 20:2001;1984-1992
115. Hong W., Kim A.Y., Ky S., Rakowski C., Seo S.B., Chakravarti D., et al. Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1. Mol. Cell. Biol. 22:2002;3729-3743
116. Chrivia J.C., Kwok R.P., Lamb N., Hagiwara M., Montminy M.R., Goodman R.H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 365:1993;855-859
117. Eckner R., Ewen M.E., Newsome D., Gerdes M., DeCaprio J.A., Lawrence J.B., et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kDa protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:1994;869-884
118. Arany Z., Newsome D., Oldread E., Livingston D.M., Eckner R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature. 374:1995;81-84
119. Lee J.S., Zhang X., Shi Y. Differential interactions of the CREB/ATF family of transcription factors with p300 and adenovirus E1A. J. Biol. Chem. 271:1996;17666-17674
120. Bannister A.J., Kouzarides T. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14:1995;4758-4762
121. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414
122. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., et al. Role of CBP/P300 in nuclear receptor signalling. Nature. 383:1996;99-103
123. Polesskaya A., Naguibneva I., Fritsch L., Duquet A., Ait-Si-Ali S., Robin P., et al. CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20:2001;6816-6825
124. Bandyopadhyay D., Okan N.A., Bales E., Nascimento L., Cole P.A., Medrano E.E. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res. 62:2002;6231-6239
125. Lau O.D., Kundu T.K., Soccio R.E., Ait-Si-Ali S., Khalil E.M., Vassilev A., et al. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol. Cell. 5:2000;589-595
126. Kawasaki H., Eckner R., Yao T.P., Taira K., Chiu R., Livingston D.M., et al. Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature. 393:1998;284-289
127. Yuan Z.M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Shioya H., et al. Function for p300 and not CBP in the apoptotic response to DNA damage. Oncogene. 18:1999;5714-5717
128. Yuan Z.M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Shioya H., et al. Role for p300 in stabilization of p53 in the response to DNA damage. J. Biol. Chem. 274:1999;1883-1886
129. Takahashi N., Kawada T., Yamamoto T., Goto T., Taimatsu A., Aoki N., et al. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 277:2002;16906-16912
130. Yao T.P., Oh S.P., Fuchs M., Zhou N.D., Ch'ng L.E., Newsome D., et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell. 93:1998;361-372
131. Rebel V.I., Kung A.L., Tanner E.A., Yang H., Bronson R.T., Livingston D.M. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc. Natl. Acad. Sci. USA. 99:2002;14789-14794
132. Shikama N., Lutz W., Kretzschmar R., Sauter N., Roth J.F., Marino S., et al. Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. EMBO J. 22:2003;5175-5185
133. Roth J.F., Shikama N., Henzen C., Desbaillets I., Lutz W., Marino S., et al. Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. EMBO J. 22:2003;5186-5196
134. McManus K.J., Hendzel M.J. Quantitative analysis of CBP- and P300-induced histone acetylations in vivo using native chromatin. Mol. Cell. Biol. 23:2003;7611-7627
135. Mitsiou D.J., Stunnenberg H.G. TAC, a TBP-sans-TAFs complex containing the unprocessed TFIIAalphabeta precursor and the TFIIAgamma subunit. Mol. Cell. 6:2000;527-537
136. Gronroos E., Hellman U., Heldin C.H., Ericsson J. Control of Smad7 stability by competition between acetylation and ubiquitination. Mol. Cell. 10:2002;483-493
137. Costanzo A., Merlo P., Pediconi N., Fulco M., Sartorelli V., Cole P.A., et al. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol. Cell. 9:2002;175-186
138. Kasper L.H., Boussouar F., Ney P.A., Jackson C.W., Rehg J., van Deursen J.M., et al. A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature. 419:2002;738-743
139. Tomita A., Towatari M., Tsuzuki S., Hayakawa F., Kosugi H., Tamai K., et al. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300. Oncogene. 19:2000;444-451
140. Sano Y., Ishii S. Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. J. Biol. Chem. 276:2001;3674-3682
141. Li Q.J., Yang S.H., Maeda Y., Sladek F.M., Sharrocks A.D., Martins-Green M. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. EMBO J. 22:2003;281-291
142. Zanger K., Radovick S., Wondisford F.E. CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol. Cell. 7:2001;551-558
143. Perissi V., Dasen J.S., Kurokawa R., Wang Z., Korzus E., Rose D.W., et al. Factor-specific modulation of CREB-binding protein acetyltransferase activity. Proc. Natl. Acad. Sci. USA. 96:1999;3652-3657
144. Impey S., Fong A.L., Wang Y., Cardinaux J.R., Fass D.M., Obrietan K., et al. Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron. 34:2002;235-244
145. Shi Y., Mello C. A CBP/p300 homolog specifies multiple differentiation pathways in Caenorhabditis elegans. Genes Dev. 12:1998;943-955
146. Victor M., Bei Y., Gay F., Calvo D., Mello C., Shi Y. HAT activity is essential for CBP-1-dependent transcription and differentiation in Caenorhabditis elegans. EMBO Rep. 3:2002;50-55
147. Ludlam W.H., Taylor M.H., Tanner K.G., Denu J.M., Goodman R.H., Smolik S.M. The acetyltransferase activity of CBP is required for wingless activation and H4 acetylation in Drosophila melanogaster. Mol. Cell. Biol. 22:2002;3832-3841
148. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498
149. Balasubramanyam K., Swaminathan V., Ranganathan A., Kundu T.K. Small molecule modulators of histone acetyltransferase p300. J. Biol. Chem. 278:2003;19134-19140